Tin tức & Cập nhật
Xem bài viết Da liễu
Xem
Chỉ hiển thị Multimedia

Dual inhibition of LAG-3, PD-1: a new therapeutic target for advanced melanoma?
25 Feb 2022
bởiAudrey Abella
In the phase II/III RELATIVITY-047 trial evaluating dual checkpoint inhibition for advanced melanoma, a new fixed-dose combination comprising the LAG-3 inhibitor relatlimab and the PD-1 inhibitor nivolumab fared better than nivolumab monotherapy.
25 Feb 2022

Microneedle technology on par with topical steroids in nail psoriasis treatment
15 Feb 2022
bởiStephen Padilla
A novel transdermal device for the delivery of triamcinolone demonstrates efficacy comparable to that of conventional topical steroids in the treatment of nail psoriasis, according to a Singapore study.
15 Feb 2022

Reaction patterns may aid in diagnosis of COVID-19 vaccine-related cutaneous side effects
02 Feb 2022
bởiStephen Padilla
A registry-based study has recently shown diverse COVID-19 vaccine-associated dermatologic reactions, including papulovesicular, pityriasis rosea-like, and papulosquamous eruptions classified as vaccine-related eruption of papules and plaques (V-REPP).
02 Feb 2022





